Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Cathébras

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Arthritis & Rheumatology (Hoboken, N.J.)|October 1, 2020
Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis With Polyangiitis: Data From a European Collaborative StudyAlice Canzian, Nils Venhoff, Maria Letizia Urban, et al.
EMBO Molecular Medicine|June 17, 2026
Systems serology identifies FcR-related autoantibody signatures and functions for Sjögren's syndromeMartin Killian, Suzanne K Shoffner-Beck, Timon Damelang, et al.
The Lancet. Rheumatology|January 22, 2024
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort studyAlessandra Bettiol, Maria Letizia Urban, Roberto Padoan, et al.
Journal of Autoimmunity|March 27, 2025
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative studyIrene Mattioli, Maria Letizia Urban, Roberto Padoan, et al.
Frontiers in Immunology|March 31, 2018
Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome RegistryMaria Elena Maccari, Hassan Abolhassani, Asghar Aghamohammadi, et al.
The Journal of Allergy and Clinical Immunology|June 30, 2023
Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunityMaria Elena Maccari, Martin Wolkewitz, Charlotte Schwab, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Arthritis & Rheumatology (Hoboken, N.J.)|October 1, 2020
Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis With Polyangiitis: Data From a European Collaborative StudyAlice Canzian, Nils Venhoff, Maria Letizia Urban, et al.
EMBO Molecular Medicine|June 17, 2026
Systems serology identifies FcR-related autoantibody signatures and functions for Sjögren's syndromeMartin Killian, Suzanne K Shoffner-Beck, Timon Damelang, et al.
The Lancet. Rheumatology|January 22, 2024
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort studyAlessandra Bettiol, Maria Letizia Urban, Roberto Padoan, et al.
Journal of Autoimmunity|March 27, 2025
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative studyIrene Mattioli, Maria Letizia Urban, Roberto Padoan, et al.
Frontiers in Immunology|March 31, 2018
Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome RegistryMaria Elena Maccari, Hassan Abolhassani, Asghar Aghamohammadi, et al.
The Journal of Allergy and Clinical Immunology|June 30, 2023
Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunityMaria Elena Maccari, Martin Wolkewitz, Charlotte Schwab, et al.
Pageof 6